The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions

被引：0
|
作者：
Afshar-Oromieh, A. [1 ]
Hetzheim, H. [2 ]
Kratochwil, C. [1 ]
Benesova, M. [3 ]
Eder, M. [4 ]
Neels, O.
Kuebler, W. [5 ]
Giesel, F. L. [1 ]
Mier, W. [6 ]
Kopka, K. [4 ]
Haberkorn, U. [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany
[3] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[4] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[5] German Canc Res Ctr, Div Radiat Protect & Dosimetry, Heidelberg, Germany
[6] Univ Heidelberg Hosp, Div Radiochem, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP429
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [41] The accuracy of PSMA PET/CT for assessing intraprostatic lesions in patients with prostate cancer: An evaluation of the PI-RADS, PRIMARY and PSMA-expression score
    Donck, E.
    De Visschere, P.
    Van Praet, C.
    De Man, K.
    Waterschoot, R.
    Verbeke, S.
    Hendrickx, S.
    Villeirs, G.
    Berquin, C.
    Lumen, N.
    EUROPEAN UROLOGY, 2024, 85 : S1616 - S1617
  • [42] 177Lu PSMA-617 in advanced castration resistant prostate cancer patients:dosimetry and preliminary evaluation of IRST 185.03 phase II prospective study
    Sansovini, M.
    Sarnelli, A.
    Severi, S.
    Foca, F.
    Celli, M.
    Monti, M.
    Nicolini, S.
    Tardelli, E.
    Belli, M.
    Matteucci, F.
    Giganti, M.
    Di Iorio, V.
    De Giorgi, U.
    Paganellli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S236 - S236
  • [43] PET–CT with (68 Ga)Gallium-Labeled PSMA Ligand for the Diagnosis of Prostate Cancer: Clinical Applications and Protocols
    Rigo L.
    de Bona Pessoa D.
    Borges A.C.
    da Cunha P.G.
    Vargas F.R.
    Current Radiology Reports, 4 (12)
  • [44] Preliminary comparative study between 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in patients with prostate cancer biodistribution and tumor detection
    Chen, Sirong
    Wong, Yuet Hung
    Tsoi, Tung Tung
    Leung, Yim Lung
    Cheng, Kam Chau
    Wong, Ka Nin
    Cheung, William
    Wu, Kwan Kit
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [45] Feasibility, Biodistribution, and Preliminary Dosimetry in PSMA Targeted Radionuclide Therapy of Metastatic Castrationa_'Resistant Prostate Cancer Using 177Lu-PSMA-087: First-in-Humans Results
    Lv, Jie
    Zhao, Ruiyue
    Liang, Sihao
    Li, Mingzhao
    Gu, Di
    Cai, Chao
    Liu, Yongda
    Zhong, Huizhen
    Fu Yimin
    Yan, Qingsong
    Zhu, Lin
    Kung, Hank F.
    Wang, Xinlu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [46] An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application
    Dietlein, Felix
    Hohberg, Melanie
    Kobe, Carsten
    Zlatopolskiy, Boris D.
    Krapf, Philipp
    Endepols, Heike
    Taeger, Philipp
    Hammes, Jochen
    Heidenreich, Axel
    Neumaier, Bernd
    Drzezga, Alexander
    Dietlein, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 202 - 209
  • [47] Dual-Time Point Evaluation of Prostate Cancer Lesions detected by 68Ga-PSMA PET/CT
    Sobral Violante, L.
    Sampaio, I.
    Teixeira, J.
    Ferreira, G.
    Duarte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S338 - S338
  • [48] [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
    Rosar, Florian
    Schaefer-Schuler, Andrea
    Bartholomae, Mark
    Maus, Stephan
    Petto, Sven
    Burgard, Caroline
    Prive, Bastiaan M.
    Franssen, Gerben M.
    Derks, Yvonne H. W.
    Nagarajah, James
    Khreish, Fadi
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (13) : 4736 - 4747
  • [49] [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
    Florian Rosar
    Andrea Schaefer-Schuler
    Mark Bartholomä
    Stephan Maus
    Sven Petto
    Caroline Burgard
    Bastiaan M. Privé
    Gerben M. Franssen
    Yvonne H. W. Derks
    James Nagarajah
    Fadi Khreish
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4736 - 4747
  • [50] A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT-Protocol design and rationale
    Alberts, Ian
    Buetikofer, Lukas
    Rominger, Axel
    Afshar-Oromieh, Ali
    PLOS ONE, 2022, 17 (07):
12345